The Global Rheumatology Alliance Patient Experience Survey has been launched.
About the Study
The COVID-19 (Novel coronavirus) pandemic has quickly infected over a million people worldwide. While most people with COVID-19 infections have mild or no symptoms, a significant proportion of patients can become quite ill. At this time, little is known about how patients with rheumatic diseases, many of whom use medications and drugs that suppress the immune system, are affected by the virus. We hope to recruit adults with rheumatic diseases, and parents of children with rheumatic diseases into our study to obtain insights about how best to prevent or treat COVID-19 in this potentially vulnerable population.
The survey can be viewed here: www.rheum-covid.org/patient-survey
The Global Rheumatology Alliance mission is to create a secure, de-identified, international case reporting registry and curate and disseminate the outputs from that registry.
It is their hope that the information collected will help guide rheumatology clinicians in assessing and treating patients with rheumatologic disease and in evaluating the risk of infection in patients on immunosuppression.